Within the tumour microenvironment, BTLA-HVEM signalling plays a critical role in suppressing anti-tumour immunity: HVEM expressed by tumour or stromal cells engages BTLA on T cells, driving T cell exhaustion (63–65). This evidence concerns the gene TNFRSF14 and neoplasm.